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Abstract: Idiopathic normal pressure hydrocephalus (iNPH) is a neuropsychiatric disease characterized by
gait disturbance, cognitive deterioration and urinary incontinence associated with excessive accumulation
of cerebrospinal fluid (CSF) in the brain ventricles. These symptoms, in particular gait disturbance,
can be potentially improved by shunt operation in the early stage of the disease, and the intervention
associates with a worse outcome when performed late during the course of the disease. Despite the
variable outcome of shunt operation, noninvasive presurgical prediction methods of shunt response have
not been established yet. In the present study, we used normalized power variance (NPV), a sensitive
measure of the instability of cortical electrical activity, to analyze cortical electrical activity derived from
EEG data using exact-low-resolution-electromagnetic-tomography (eLORETA) in 15 shunt responders
and 19 non-responders. We found that shunt responders showed significantly higher NPV values at
high-convexity areas in beta frequency band than non-responders. In addition, using this difference,
we could discriminate shunt responders from non-responders with leave-one-subject-out cross-validation
accuracy of 67.6% (23/34) [positive predictive value of 61.1% (11/18) and negative predictive value of
75.0% (12/16)]. Our findings indicate that eLORETA-NPV can be a useful tool for noninvasive prediction
of clinical response to shunt operation in patients with iNPH.
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Idiopathic normal pressure hydrocephalus (iNPH) is a neuropsychiatric disease characterized by gait 
disturbance, cognitive deterioration and urinary incontinence associated with excessive accumulation 
of cerebrospinal fluid (CSF) in the brain ventricles. These symptoms, in particular gait disturbance, 
can be potentially improved by shunt operation in the early stage of the disease, and the intervention 
associates with a worse outcome when performed late during the course of the disease. Despite the 
variable outcome of shunt operation, noninvasive presurgical prediction methods of shunt response 
have not been established yet. In the present study, we used normalized power variance (NPV), a 
sensitive measure of the instability of cortical electrical activity, to analyze cortical electrical activity 
derived from EEG data using exact‑low‑resolution‑electromagnetic‑tomography (eLORETA) in 15 
shunt responders and 19 non‑responders. We found that shunt responders showed significantly higher 
NPV values at high‑convexity areas in beta frequency band than non‑responders. In addition, using 
this difference, we could discriminate shunt responders from non‑responders with leave‑one‑subject‑
out cross‑validation accuracy of 67.6% (23/34) [positive predictive value of 61.1% (11/18) and negative 
predictive value of 75.0% (12/16)]. Our findings indicate that eLORETA‑NPV can be a useful tool for 
noninvasive prediction of clinical response to shunt operation in patients with iNPH.
Idiopathic normal pressure hydrocephalus (iNPH) is a neuropsychiatric disorder characterized by symptoms of 
gait disturbance, cognitive deterioration and urinary incontinence without any preceding diseases. Brain imaging 
by Magnetic Resonance Imaging (MRI) and Computed Tomography (CT) shows typical morphologic abnor-
malities such as ventriculomegaly, dilation of the Sylvian fissures and narrowing of the sulci and subarachnoid 
spaces over the high-convexity area of the brain, indicating excessive accumulation of cerebrospinal fluid (CSF) 
in the  ventricles1. This morphological feature was defined as disproportionately enlarged subarachnoid-space 
hydrocephalus (DESH) in Japanese diagnostic criteria for  iNPH1. The prevalence of possible iNPH was reported 
to be 1–2% in the elderly population by recent community or population-based  studies1–6. However, many elderly 
patients with iNPH remain undiagnosed and untreated.
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Unlike other types of dementia, iNPH has symptoms, especially gait disturbance, that can be potentially 
recovered with CSF shunt operation. Surgery is not effective in all cases, and when it is delayed there are less 
chances of getting a good clinical  outcome7–9. Therefore, identifying predictive factors of shunt response is of 
considerable clinical importance. Japanese clinical guidelines for iNPH recommended “CSF tap test” by draining 
30 ml of CSF by lumbar puncture to estimate possible shunt response based on symptoms  recovery1. However, 
lumbar punction is an invasive procedure having some risks, including infection, bleeding and postural head-
ache. In addition, it has the problem of low negative predictive value (18–50%) which means that patients that 
do not respond to the lumbar tapping (CSF tap negative patients) may show symptoms improvement if shunt 
operation is  performed10–12. Several recent MRI studies found that presurgical morphological features of iNPH 
(e.g. high-convexity tightness, Sylvian fissure dilation and steep callosal angle) were related to a better shunt 
 response13–15. However, prediction of shunt response based only on a morphological feature of DESH also suffers 
from a low negative predictive value (25%)16. Some studies using Single Photon Emission Computed Tomography 
(SPECT) and Positron Emission Tomography (PET) reported that shunt responders showed significant lower 
cerebral blood flow in the basal frontal lobes compared to non-responders17,18. Most PET, SPECT or functional 
MRI (fMRI) studies, however, have failed to detect presurgical difference in cerebral blood flow between shunt 
responders and non-responders before shunt  operation1.
Electroencephalography (EEG) is a noninvasive and widely available tool commonly used in neuroscience 
research to investigate cortical electrical activities. It is also used in clinical practice to support diagnoses of 
epilepsy, disturbance of consciousness and dementia. Unlike PET, SPECT and fMRI which measure glucose 
metabolism or blood flow changes secondary to cortical activities, EEG directly measures electrical potentials 
with high temporal resolution (1–2 ms). This activity can be obtained through electrodes placed on the scalp, 
representing a linear mixture of cortical electrical potentials from different brain sources. Thus, to visualize the 
cortical electrical activity from EEG data, it is necessary to solve a linear inverse problem of EEG. Exact-low-
resolution-brain-electromagnetic-tomography (eLORETA) is a linear inverse solution that reconstructs cortical 
electrical activity from EEG data with correct  localization19–23. eLORETA with EEG data has been widely used 
in neuroscience  studies20,24–28. However, traditional EEG power spectral analysis and eLORETA analysis have 
failed to discriminate shunt responders from non-responders29. In a previous study using EEG and normalized 
power variance (NPV) analysis, a sensitive measure of the instability of cortical electrical  activity19,30, we showed 
that shunt responders had significantly higher NPV at the right fronto-temporo-occipital electrodes (Fp2, T4 
and O2) in beta frequency band compared to non-responders29.
NPV is theoretically thought to sensitively reflect the instability of cortical electrical activity related to phase 
 transition30. Using NPV analysis with EEG data in epilepsy, we demonstrated the high sensitivity of this method 
to visualize the instability of cortical electrical activity at the seizure onset zone in the pre-ictal phase and its 
stabilization after transition to the ictal  phase19. In this study, we could assume a phase transition from instability 
of cortical electrical activity in shunt responders to stabilization in non-responders because pathophysiological 
changes in these patients are in reversible and irreversible to shunt operation,  respectively30. Thus, we decided 
to apply NPV analysis with eLORETA cortical electrical activity (eLORETA-NPV analysis), as it is able to detect 
differences in phase-instability of cortical electrical activity between shunt responders and non-responders.
In the present study, using eLORETA-NPV analysis, we aimed to detect differences in cortical electrical oscil-
lations between shunt responders and non-responders and to determine cortical regions responsible for shunt 
response. This would provide valuable information for improving prediction of shunt response and understand-
ing the neurophysiological mechanisms of symptom recoveries induced by shunt operation in iNPH.
Results
Demographic and clinical results. We classified 34 iNPH patients into 15 shunt responders and 19 non-
responders based on shunt operation outcome, as described in the Methods section. Most of the patients in the 
shunt responder group showed improvement only in the gait domain, except for a patient who showed improve-
ment in both gait and cognitive domains and another patient who showed improvement only in the cognitive 
domain. Demographic and clinical characteristics of our subjects are shown in Table 1. There were no significant 
group differences for age, gender, and clinical scores. The rate of shunt responders was relatively low because 
our classification criteria of shunt response were more stringent than those of the Japanese Clinical Guidelines 
in order to select patients who demonstrated significant improvements in gait and cognitive symptoms as shunt 
 responders31.
eLORETA analysis results. There was no significant difference in cortical electrical activities between 
shunt responders and non-responders, as indicated by eLORETA analysis.
eLORETA‑NPV analysis results. Shunt responders showed significantly higher eLORETA-NPV values at 
high-convexity areas (i.e. cingulate gyrus, paracentral lobule and medial frontal gyrus) in beta frequency band 
relative to non-responders as shown in Figs. 1, 2, 3 [extreme p = 0.044 at the cingulate gyrus (X = 5, Y =  − 15, 
Z = 45; MNI coordinates)]. Using this beta eLORETA-NPVs at the cingulate gyrus, discriminant function analy-
sis yielded a discriminant function that predicts shunt response. The function is as follows: 
 where positive and negative scores indicate positive and negative shunt response respectively. This index could 
correctly discriminate shunt responders from non-responders with leave-one-subject-out cross-validation accu-
racy of 67.6% (23/34) [positive predictive value of 61.1% (11/18) and negative predictive value of 75.0% (12/16)].
Prediction score = log(beta eLORETA-NPV) + 1.49
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Table 1.  Cognitive and gait function test scores of Shunt responders and Non-responders. Data are 
mean ± SD. Difference in the female to male ratios of shunt responders and non-responders is assessed using 
Chi-square test. Differences in the other scores are assessed using paired Student’s t test (uncorrected). WT: 
10-m reciprocating walking test, TUG: 3 m Timed Up and Go, GSSR: Gait Status Scale-Revised, MMSE: 
Mini-Mental State Examination, FAB: Frontal Assessment Battery, TMT-A: Trail Making Test Part A, WMS-R: 
Wechsler Memory Scale-Revised, WAIS-III: Wechsler Adult Intelligence Scale-III.
Test Shunt responders Non-responders p-value
Gender (F/M) 6/9 8/11 0.90
Age 75.0 ± 6.6 76.0 ± 6.0 0.93
WT 27.5 ± 19.6 21.8 ± 6.3 0.32
TUG 15.8 ± 5.8 13.7 ± 4.9 0.26
GSSR 6.9 ± 3.2 6.0 ± 2.0 0.34
MMSE 23.2 ± 3.7 24.4 ± 3.9 0.34
FAB 11.1 ± 2.7 11.8 ± 2.6 0.42
TMT-A 119 ± 78 105 ± 90 0.65
WMS-R_Attention/Concentration index 80.0 ± 15.2 85.7 ± 12.1 0.24
WAIS-III-Digit Symbol-Coding 5.8 ± 2.7 7.2 ± 2.6 0.14
WAIS-III-Block Design 6.5 ± 3.0 7.3 ± 2.1 0.43
Figure 1.  eLORETA-NPV in beta frequency band of Shunt responders. Mean eLORETA-NPV value in beta 
frequency band of 15 Shunt responders. Normalized power variance (NPV) of eLORETA cortical electrical 
activity is color coded from grey (zero) to red to bright yellow (maximum). Slices from left to right are axial, 
sagittal and coronal images (viewed from top, left and back). L, left; R, right; A, anterior; P, posterior.
Figure 2.  eLORETA-NPV in beta frequency band of Non-responders. Mean eLORETA-NPV value in beta 
frequency band of 19 Non-responders. Normalized power variance (NPV) of eLORETA cortical electrical 
activity is color coded from grey (zero) to red to bright yellow (maximum). Slices from left to right are axial, 
sagittal and coronal images (viewed from top, left and back). L, left; R, right; A, anterior; P, posterior.
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Discussion
In this study, we employed eLORETA-NPV analysis, a sensitive measure of the instability of cortical electrical 
activity, to determine cortical regions related to shunt response and to find EEG predictive markers of shunt 
response in patients with iNPH. Our main findings were that: (1) shunt responders had significantly higher 
eLORETA-NPV values at high-convexity areas in beta frequency band relative to non-responder (Figs. 1, 2, 
3), and (2) using this difference in eLORETA-NPV values, we could correctly discriminate shunt responders 
from non-responders with a positive predictive value of 61.1% (11/18) and a negative predictive value of 75.0% 
(12/16) with cross-validation.
The high-convexity areas found associated with shunt response in our study are regions considered to be 
compressed by dilated ventricles in iNPH. The reduction of this compression might be associated with the patho-
physiological mechanisms of symptoms recovery induced by shunt  operation1,13–15. In support to our results, 
several recent studies using MRI showed that presurgical compression of high-convexity areas was a significant 
predictor of better shunt operation  outcome13–15. A recent large-scale MRI study reported lack of correlation 
between presurgical MRI morphological features and postsurgical  outcome32. In that study, the majority of 
iNPH patients did not undergo CSF tap test. Most SPECT, PET and fMRI studies have failed to detect differ-
ence in cerebral blood flow between shunt responders and non-responders prior to shunt  operation1. Similarly, 
traditional EEG power spectral analysis and eLORETA analysis have failed to discriminate shunt responders 
from non-responders29. Unlike these neuroimaging modalities, eLORETA-NPV analysis with EEG data could 
detect difference of cortical electrical activities related to shunt response at high-convexity areas. To date, for 
prediction of shunt response CSF tap test has been the method used in clinical practice in iNPH. However, as 
previously mentioned, CSF tapping is an invasive procedure, and has several risks (e.g. infection, bleeding and 
post-punction headache). Our finding suggests that eLORETA-NPV value at the high-convexity areas in beta 
frequency band can be a noninvasive predictive marker of shunt response without the need of performing a 
lumbar puncture to assess symptoms improvement.
It is noteworthy that the difference in cortical electrical activity between shunt responders and non-responders 
in this study was found in beta frequency band. Responders mainly improved in gait disturbance. This result of 
frequency band seems to be in line with the role of beta oscillations in motor control. Furthermore, abnormalities 
in this frequency band have been closely associated with motor  disorders33,34. Interestingly, in our previous study 
using NPV analysis with EEG data, differences in EEG oscillations in iNPH patients were also found in the beta 
 band29. Consistent with the source location finding at the right convexity areas in this study, we have provided 
evidence using eLORETA-ICA indicating that the right ventral attention network was involved in gait speed 
recovery after CSF  drainage27. Also, in support to our findings, recent neuroimaging and electrophysiological 
studies revealed that the cortical locomotor network consists of dorsal and ventral pathways. Interestingly, the 
dorsal and ventral locomotor networks encompass areas of the paracentral sensorimotor cortex and ventral 
attention network regions,  respectively35,36.
In this study, we assumed a functional transition from reversible phase to irreversible phase in iNPH (i.e. 
from shunt responder to non-responder). Theoretically, Thermal and statistical physics suggests that a reversible 
phase is unstable and irreversible phase is a stable state, showing high and low variances of state parameters, 
 respectively30. This supports our result of shunt responders showed significantly higher eLORETA-NPV values 
compared to non-responders.
This is the first study demonstrating that, unlike other methods such as SPECT, PET, fMRI, and EEG with 
eLORETA power analysis that have been used to investigate brain activity, EEG with eLORETA-NPV analysis can 
detect differences in cortical electrical oscillations between shunt responders and non-responders and localize 
Figure 3.  Log of F-ratio of eLORETA-NPV in beta frequency band between Shunt responders and Non-
responders. Shunt responders had significantly higher normalized power variance (NPV) of eLORETA cortical 
electrical activity in beta frequency band at the high-convexity area (cingulate gyrus, paracentral lobule and 
medial frontal gyrus) compared to Non-responders. Log of F-ratio of eLORETA-NPV values in beta frequency 
band between 15 shunt responders and 19 non-responders above threshold (p < 0.05) is color coded red to 
bright yellow (maximum). Slices from left to right are axial, sagittal and coronal images (viewed from top, left 
and back). L, left; R, right; A, anterior; P, posterior.
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the brain sources associated with shunt operation outcome in iNPH patients. This may be attributed to the fact 
that EEG directly detects cortical electrical activity with high temporal resolution (milliseconds), eLORETA 
analysis reconstructs cortical electrical activity from EEG data with correct localization and that NPV analysis 
sensitively detect instability of cortical electrical activity. Overall findings indicate that eLORETA-NPV is a 
useful and sensitive tool to assess cortical states and can provide valuable information for understanding the 
neurophysiological mechanisms underlying this disease.
Our results should be interpreted with caution based on the following limitations. First, the sample size of 
iNPH patients was relatively small. Therefore, our findings should be considered as preliminary, and replicated in 
larger samples. Nevertheless, our main results of eLORETA-NPV difference between shunt responders and non-
responders are in line with previous neuroimaging findings of iNPH. This allows us to suggest that eLORETA-
NPV is a reliable measure of instability of cortical electrical activity. Second, patients with iNPH have atrophy and 
deformation of the brain cortex relative to the realistic head model used in eLORETA-NPV. However, we found 
difference in eLORETA-NPV values between shunt responders and non-responders among several lobules at 
the high-convexity area. This may indicate that our results are robust to cortical atrophy and deformation effect. 
Third, results of analysis of variance (ANOVA) were uncorrected for the five tests performed on eLORETA-NPV 
data for each frequency band. This was because eLORETA-NPV values of each frequency band followed the chi-
squared distribution of different degrees of freedom. Thus, we could not apply the permutation test implemented 
in eLORETA Statistics to frequency domain of eLORETA-NPV data to correct for multiple  comparisons37. How-
ever, our eLORETA-NPV results of beta frequency band and cortical regions discriminating shunt responders 
from non-responders were consistent with findings from previous neuroimaging studies of  iNPH13–15,29.
Overall, a finding with important therapeutic implications of our study is that eLORETA-NPV analysis can 
be used for prediction of response to shunt operation in patients with iNPH. It is promising that eLORETA-NPV 
may also be useful to assess or predict brain states in patients with other neuropsychiatric disorders.
Methods
Subjects. Definite and probable iNPH patients who underwent shunt operation at the Department of Neu-
rosurgery of Osaka University Hospital between April 2010 and May 2019 were consecutively recruited from 
the Neuropsychology Clinic at the Department of Psychiatry of Osaka University Hospital. CSF tap test was 
performed on all patients. Then, patients who showed positive response underwent shunt operation according 
to the Japanese Clinical Guidelines for  iNPH1.
The inclusion criteria were: (1) age 60 years or older; (2) at least one of the triad symptoms: gait disturbance, 
cognitive impairment and urinary incontinence; (3) dilated cerebral ventricles and narrowed CSF space at the 
high convexity areas without severe cortical atrophy on MRI; (4) absence of diseases or conditions that might 
cause clinical symptoms and neuroimaging findings; (5) no history of severe head trauma, subarachnoid hem-
orrhage, meningitis and tumor; (6) normal CSF pressure (< 200 mm  H2O) and contents by lumbar puncture 
and (7) right handedness. Exclusion criteria were: (1) comorbidities of motor or psychiatric disorders except 
for Alzheimer’s disease (AD) (2) long-standing overt ventriculomegaly in adults (LOVA) on MRI findings and 
(3) a lack of artifact free epochs of 500-s (500-s) in the EEG recordings. We included iNPH patients with AD 
comorbidity as AD is commonly seen in iNPH and AD pathology is considered not to affect clinical recovery 
after shunt  operation38,39.
Out of 43 patients who met the inclusion criteria, two patients were excluded due to comorbidity of Parkin-
son’s disease, two patients due to LOVA on MRI findings, four patients due to lack of 500-s artifact free epochs, 
and one patient that did not complete followed up after shunt operation. Finally, 34 patients were included in 
this study.
This study was approved by the Ethics Committee of Osaka University Hospital and written informed consent 
was obtained from the patients or their families. CSF tap test and shunt operation were performed in accordance 
with the Japanese Clinical Guidelines for  iNPH1.
Gait assessment. Assessments of gait and cognition have already been described in our previous  study31. 
Briefly, gait disturbance was assessed by the 10-m reciprocating walking test (WT), the 3  m Timed Up and 
Go (TUG)  test40 and the Gait Status Scale-Revised (GSSR)41. The thresholds of improvement were set at 10% 
improvement in the WT and TUG, and 1-point improvement in the GSSR. Improvement in all gait assessments 
was defined as clinical improvement in the gait domain.
Cognitive assessment. Cognitive impairment was assessed by the Frontal Assessment Battery (FAB)42, 
Mini-Mental State Examination (MMSE)43, Wechsler Memory Scale-Revised (WMS-R)-Attention/Concentra-
tion  Index44, Wechsler Adult Intelligence Scale-III (WAIS-III)-Block  Design45, WAIS-III-Digit Symbol  Coding45, 
and Trail Making Test Part A (TMT-A)46. The improvement thresholds of the cognitive tests were set at 2, 3, 15, 
3, 3 points and 30% respectively. Improvement in more than half of the cognitive assessments was defined as 
clinical improvement in the cognitive domain.
Assessment of shunt response. Assessment of shunt response has already been described in our previ-
ous  study29. Briefly, before and after shunt operation, gait disturbance and cognitive impairment were evaluated 
at presurgical evaluation and postsurgical evaluations at 1, 3, 6 months, and 1 year. Urinary incontinence was 
excluded from assessment in our study because of low reliability, as the frequency of urination was sometimes 
self-reported. Shunt operation was judged as positive if at least one symptom showed clinical improvement at 
any time of assessment after shunt operation; otherwise it was judged as negative. Consequently, the patients 
were classified as shunt responders and non-responders. These classification criteria were more stringent than 
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those of the Japanese Clinical Guidelines for  iNPH1, because we selected patients who showed significant symp-
toms recovery as shunt  responders31.
EEG recording. EEG data acquisition and the procedure of eLORETA have already been described in detail 
in our previous  studies20,31. EEG data was recorded 1–3 month before shunt operation during eyes-closed rest-
ing-state condition for about 20 min using a 19-electrode EEG system (EEG-1000/EEG-1200, Nihon Kohden 
Inc., Tokyo, Japan), and filtered through a band-pass filter of 0.53 to 120 Hz with a sampling rate of 500 Hz. 
Subjects were instructed to relax but remain awake. During the EEG sessions, drowsiness was avoided by giving 
instructions once again. For each patient, 500-s artifact free epochs were selected off-line, and imported into 
eLORETA and eLORETA-NPV analysis.
eLORETA analysis. Here is a brief description. eLORETA is a linear weighted minimum norm inverse 
solution which has the property of correct localization albeit with low spatial  resolution22,23. The solution space 
consists of 6,239 voxels in the cortical grey matter at 5 mm spatial resolution, in a realistic head  model47 with the 
MNI152  template48. The eLORETA method has been widely used to explore cortical electrical activities and its 
validity has been proved with real human data during various sensory stimulations and in neuropsychiatric dis-
ease  studies19–21,49. In this study, eLORETA and eLORETA-NPV analyses were performed in MATLAB R2019b 
software. In eLORETA analysis, first, 500-s EEG data of each subject were transformed into the time–frequency 
domain after discrete Fourier transform using ft_freqanalysis function in Field Trip toolbox (https ://www.field 
tript oolbo x.org/) installed in MATLAB software. Then, the time–frequency data was transformed to the corti-
cal electrical current density data by multiplying spatial filter of eLORETA which was obtained using MATLAB 
program written by author R. B. This program followed a technical instruction about eLORETA provided by 
author R. D. P.-M.22 and we confirmed equality of the obtained spatial filter with that of eLORETA. Finally, 
the cortical electrical activity was obtained by squaring the cortical electrical current density. The eLORETA 
analysis was computed for five frequency bands: delta (1.5–4.0 Hz), theta (4.5–7.0 Hz), alpha (7.5–13.0 Hz), beta 
(13.5–29.5 Hz), and gamma (30.0–59.5 Hz). Before statistical comparison, to compare across different subjects, 
the subject-wise normalization implemented in eLORETA Statistics was applied to the data.
eLORETA‑NPV analysis. In eLORETA-NPV analysis program, the NPV value of cortical electrical activ-
ity was calculated at each cortical voxel for each frequency band, with eLORETA-NPV value being defined 
as the variance of cortical electrical activity divided by the square of mean cortical electrical activity for each 
4.6-s EEG epoch. Then, eLORETA-NPVs of 4.6-s EEG epochs were collected at 1.15-s steps for the whole EEG 
epoch and averaged to get the stationary mean eLORETA-NPV value (moving average filter method)31. The 
eLORETA-NPV analysis was computed for five frequency bands: delta (1.5–4.0 Hz), theta (4.5–7.0 Hz), alpha 
(7.5–13.0 Hz), beta (13.5–29.5 Hz), and gamma (30.0–59.5 Hz).
Statistical group analysis and discriminant function analysis. The differences in eLORETA-NPV 
values at each cortical voxel in each frequency band between shunt responders and non-responders were assessed 
using ANOVA implemented in eLORETA Statistics. The level of significance for this test was set at p < 0.05 with 
correction for multiple comparisons across 6,239 cortical voxels using a permutation  test37. The eLORETA-
NPV values of each frequency band followed the chi-squared distribution of different degrees of freedom, thus 
we applied the permutation test correction in eLORETA Statistics to the 6,239 cortical voxels but not to five 
frequency bands. In order to find an prediction score for shunt response, we selected eLORETA-NPV values at 
the cortical source (cingulate gyrus: X = 5, Y = − 15, Z = 45) in the specific frequency band (beta frequency) that 
showed most significant differences between the two groups as a predictor and performed discriminant function 
analysis using the SPSS software version 25.0 (SPSS Japan Inc., and IBM Company Tokyo, Japan).
Data availability
The datasets generated during and/or analyzed during the current study are available from the corresponding 
author on reasonable request.
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